SARS-CoV-2 mutations acquired in mink reduce antibody-mediated neutralization.


Journal

Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691

Informations de publication

Date de publication:
20 04 2021
Historique:
received: 29 12 2020
revised: 16 02 2021
accepted: 30 03 2021
pubmed: 16 4 2021
medline: 4 5 2021
entrez: 15 4 2021
Statut: ppublish

Résumé

Transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from humans to farmed mink has been observed in Europe and the US. In the infected animals, viral variants arose that harbored mutations in the spike (S) protein, the target of neutralizing antibodies, and these variants were transmitted back to humans. This raised concerns that mink might become a constant source of human infection with SARS-CoV-2 variants associated with an increased threat to human health and resulted in mass culling of mink. Here, we report that mutations frequently found in the S proteins of SARS-CoV-2 from mink are mostly compatible with efficient entry into human cells and its inhibition by soluble angiotensin-converting enzyme 2 (ACE2). In contrast, mutation Y453F reduces neutralization by an antibody with emergency use authorization for coronavirus disease 2019 (COVID-19) therapy and sera/plasma from COVID-19 patients. These results suggest that antibody responses induced upon infection or certain antibodies used for treatment might offer insufficient protection against SARS-CoV-2 variants from mink.

Identifiants

pubmed: 33857422
pii: S2211-1247(21)00331-4
doi: 10.1016/j.celrep.2021.109017
pmc: PMC8018833
pii:
doi:

Substances chimiques

Antibodies, Neutralizing 0
Antibodies, Viral 0
Spike Glycoprotein, Coronavirus 0
spike protein, SARS-CoV-2 0
ACE2 protein, human EC 3.4.17.23
Angiotensin-Converting Enzyme 2 EC 3.4.17.23

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

109017

Informations de copyright

Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests The authors declare no competing interests.

Références

Science. 2021 Jan 8;371(6525):172-177
pubmed: 33172935
Science. 2020 Nov 13;370(6518):754
pubmed: 33184189
Vet Pathol. 2020 Sep;57(5):653-657
pubmed: 32663073
N Engl J Med. 2020 Aug 6;383(6):592-594
pubmed: 32402157
Cell. 2020 Aug 20;182(4):812-827.e19
pubmed: 32697968
Cell. 2021 Jan 7;184(1):169-183.e17
pubmed: 33296701
Euro Surveill. 2020 Jun;25(23):
pubmed: 32553059
PLoS One. 2017 Dec 7;12(12):e0189073
pubmed: 29216247
Cell. 2020 Sep 3;182(5):1295-1310.e20
pubmed: 32841599
Science. 2020 May 29;368(6494):1016-1020
pubmed: 32269068
Proc Natl Acad Sci U S A. 2005 Sep 27;102(39):14040-5
pubmed: 16169905
Cell. 2009 Dec 24;139(7):1243-54
pubmed: 20064371
Viruses. 2021 Jan 15;13(1):
pubmed: 33467732
J Gene Med. 2006 Aug;8(8):1037-47
pubmed: 16779863
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
Cell. 2020 May 14;181(4):905-913.e7
pubmed: 32333836
Cell. 2020 May 14;181(4):894-904.e9
pubmed: 32275855
Science. 2020 Aug 21;369(6506):1010-1014
pubmed: 32540901
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
PLoS One. 2011;6(10):e25858
pubmed: 21998709
Nature. 2020 Jul;583(7815):286-289
pubmed: 32380510
Nature. 2021 Apr;592(7852):116-121
pubmed: 33106671
PLoS One. 2014 Feb 21;9(2):e89529
pubmed: 24586849
Science. 2003 Oct 10;302(5643):276-8
pubmed: 12958366
Proc Natl Acad Sci U S A. 2020 Oct 6;117(40):24790-24793
pubmed: 32948692
Science. 2020 Aug 21;369(6506):1014-1018
pubmed: 32540904
Lancet Infect Dis. 2021 Jan;21(1):18-19
pubmed: 33227234
Nature. 2020 Jul;583(7815):282-285
pubmed: 32218527
Science. 2020 Nov 27;370(6520):1110-1115
pubmed: 33037066
Science. 2020 Sep 25;369(6511):1586-1592
pubmed: 32694201
mBio. 2020 Oct 13;11(5):
pubmed: 33051368
J Virol. 2019 Jan 4;93(2):
pubmed: 30404801
Science. 2020 Dec 4;370(6521):1227-1230
pubmed: 33115920
Nature. 2020 May;581(7807):215-220
pubmed: 32225176
N Engl J Med. 2020 Dec 31;383(27):2603-2615
pubmed: 33301246
Science. 2005 Oct 28;310(5748):676-9
pubmed: 16195424

Auteurs

Markus Hoffmann (M)

Infection Biology Unit, German Primate Center - Leibniz Institute for Primate Research, Kellnerweg 4, 37077 Göttingen, Germany; Faculty of Biology and Psychology, University Göttingen, Wilhelmsplatz 1, 37073 Göttingen, Germany. Electronic address: mhoffmann@dpz.eu.

Lu Zhang (L)

Infection Biology Unit, German Primate Center - Leibniz Institute for Primate Research, Kellnerweg 4, 37077 Göttingen, Germany; Faculty of Biology and Psychology, University Göttingen, Wilhelmsplatz 1, 37073 Göttingen, Germany.

Nadine Krüger (N)

Infection Biology Unit, German Primate Center - Leibniz Institute for Primate Research, Kellnerweg 4, 37077 Göttingen, Germany.

Luise Graichen (L)

Infection Biology Unit, German Primate Center - Leibniz Institute for Primate Research, Kellnerweg 4, 37077 Göttingen, Germany.

Hannah Kleine-Weber (H)

Infection Biology Unit, German Primate Center - Leibniz Institute for Primate Research, Kellnerweg 4, 37077 Göttingen, Germany; Faculty of Biology and Psychology, University Göttingen, Wilhelmsplatz 1, 37073 Göttingen, Germany.

Heike Hofmann-Winkler (H)

Infection Biology Unit, German Primate Center - Leibniz Institute for Primate Research, Kellnerweg 4, 37077 Göttingen, Germany.

Amy Kempf (A)

Infection Biology Unit, German Primate Center - Leibniz Institute for Primate Research, Kellnerweg 4, 37077 Göttingen, Germany; Faculty of Biology and Psychology, University Göttingen, Wilhelmsplatz 1, 37073 Göttingen, Germany.

Stefan Nessler (S)

Institute of Neuropathology, University Medical Center Göttingen, Robert-Koch-Straße 40, 37075 Göttingen, Germany.

Joachim Riggert (J)

Department of Transfusion Medicine, University Medical Center Göttingen, Robert-Koch-Straße 40, 37075 Göttingen, Germany.

Martin Sebastian Winkler (MS)

Department of Anaesthesiology and Intensive Care Medicine, University of Göttingen Medical Center, Göttingen, Georg-August University of Göttingen, Robert-Koch-Straße 40, 37075 Göttingen, Germany.

Sebastian Schulz (S)

Division of Molecular Immunology, Department of Internal Medicine 3, Friedrich-Alexander University of Erlangen-Nürnberg, Glückstraße 6, 91054 Erlangen, Germany.

Hans-Martin Jäck (HM)

Division of Molecular Immunology, Department of Internal Medicine 3, Friedrich-Alexander University of Erlangen-Nürnberg, Glückstraße 6, 91054 Erlangen, Germany.

Stefan Pöhlmann (S)

Infection Biology Unit, German Primate Center - Leibniz Institute for Primate Research, Kellnerweg 4, 37077 Göttingen, Germany; Faculty of Biology and Psychology, University Göttingen, Wilhelmsplatz 1, 37073 Göttingen, Germany. Electronic address: spoehlmann@dpz.eu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH